CHAPTER 1. RESEARCH-GRADE PROTEINS MARKET: METHODOLOGY AND SCOPE
1.1. MARKET SEGMENTATION AND SCOPE
1.2. MARKET DEFINITIONS
1.2.1. PRODUCT SEGMENT
1.2.2. HOST CELL SEGMENT
1.2.3. END USE SEGMENT
1.3. RESEARCH ASSUMPTIONS
1.4. INFORMATION PROCUREMENT
1.4.1. PRIMARY RESEARCH
1.5. INFORMATION OR DATA ANALYSIS
1.6. MARKET FORMULATION & VALIDATION
1.7. MARKET MODEL
1.8. GLOBAL MARKET: CAGR CALCULATION
1.9. OBJECTIVES
CHAPTER 2. RESEARCH-GRADE PROTEINS MARKET: EXECUTIVE SUMMARY
2.1. MARKET OUTLOOK
2.2. SEGMENT SNAPSHOT
2.3. COMPETITIVE LANDSCAPE SNAPSHOT
CHAPTER 3. RESEARCH-GRADE PROTEINS MARKET VARIABLES, TRENDS, & SCOPE
3.1. MARKET LINEAGE OUTLOOK
3.1.1. PARENT MARKET OUTLOOK
3.1.2. RELATED/ANCILLARY MARKET OUTLOOK
3.2. MARKET TRENDS AND OUTLOOK
3.3. MARKET DYNAMICS
3.3.1. MARKET DRIVERS ANALYSIS
3.3.1.1. INCREASING USE OF RECOMBINANT PROTEINS IN RESEARCH ACTIVITIES
3.3.1.2. GROWING RESEARCH ACTIVITIES FOR DRUG DISCOVERY AND PRECISION MEDICINE
3.3.1.3. RISING ADOPTION OF BIOLOGICS & BIOSIMILARS
3.3.2. MARKET RESTRAINT ANALYSIS
3.3.2.1. REGULATORY AND SAFETY CONCERNS REGARDING PROTEIN PRODUCTION
3.3.2.2. DEARTH OF SKILLED PERSONNEL AND EXPERTISE
3.4. BUSINESS ENVIRONMENT ANALYSIS
3.4.1. PESTEL ANALYSIS
3.4.2. PORTER’S FIVE FORCES ANALYSIS
3.4.3. COVID-19 IMPACT ANALYSIS
CHAPTER 4. PRODUCT BUSINESS ANALYSIS
4.1. PRODUCT SEGMENT DASHBOARD
4.2. RESEARCH-GRADE PROTEINS MARKET: PRODUCT MOVEMENT ANALYSIS
4.3. GLOBAL RESEARCH-GRADE PROTEINS MARKET SIZE & TREND ANALYSIS, BY PRODUCT, 2024 TO 2033
4.4. CYTOKINES & GROWTH FACTORS
4.4.1. CYTOKINES & GROWTH FACTORS MARKET,
4.4.2. INTERFERONS (IFNS)
4.4.2.1. INTERFERONS (IFNS) MARKET,
4.4.3. INTERLEUKINS (ILS)
4.4.3.1. INTERLEUKINS (ILS) MARKET,
4.4.4. OTHERS
4.4.4.1. OTHERS MARKET,
4.5. ANTIBODIES
4.5.1. ANTIBODIES,
4.6. IMMUNE CHECKPOINT PROTEINS
4.6.1. IMMUNE CHECKPOINT PROTEINS MARKET,
4.7. VIRUS ANTIGENS
4.7.1. VIRUS ANTIGENS MARKET,
4.8. ENZYMES
4.8.1. ENZYMES MARKET,
4.8.2. KINASES
4.8.2.1. KINASES MARKET,
4.8.3. METABOLIC ENZYMES
4.8.3.1. METABOLIC ENZYMES MARKET,
4.8.4. OTHERS
4.8.4.1. OTHERS MARKET,
4.9. RECOMBINANT REGULATORY PROTEINS
4.9.1. RECOMBINANT REGULATORY PROTEINS MARKET,
4.10. HORMONES
4.10.1. HORMONES MARKET,
4.11. OTHERS
4.11.1. OTHERS MARKET,
CHAPTER 5. HOST CELL BUSINESS ANALYSIS
5.1. HOST CELL SEGMENT DASHBOARD
5.2. RESEARCH-GRADE PROTEINS MARKET: HOST CELL MOVEMENT ANALYSIS
5.3. GLOBAL RESEARCH-GRADE PROTEINS MARKET SIZE & TREND ANALYSIS, BY HOST CELL, 2024 TO 2033
5.4. MAMMALIAN CELLS
5.4.1. MAMMALIAN CELLS MARKET,
5.5. BACTERIAL CELLS
5.5.1. BACTERIAL CELLS MARKET,
5.6. YEAST & FUNGI
5.6.1. YEAST & FUNGI MARKET,
5.7. INSECT CELLS
5.7.1. INSECT CELLS MARKET,
5.8. OTHERS
5.8.1. OTHERS MARKET,
CHAPTER 6. END USE BUSINESS ANALYSIS
6.1. END USE SEGMENT DASHBOARD
6.2. RESEARCH-GRADE PROTEINS MARKET: END USE MOVEMENT ANALYSIS
6.3. GLOBAL RESEARCH-GRADE PROTEINS MARKET SIZE & TREND ANALYSIS, BY END USE, 2024 TO 2033
6.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
6.4.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET,
6.5. ACADEMIC & RESEARCH INSTITUTES
6.5.1. ACADEMIC & RESEARCH INSTITUTES MARKET,
6.6. OTHERS
6.6.1. OTHERS MARKET,
CHAPTER 7. REGIONAL BUSINESS ANALYSIS
7.1. REGIONAL DASHBOARD
7.2. MARKET SIZE & FORECASTS AND TREND ANALYSIS, 2018 TO 2030
7.3. NORTH AMERICA
7.3.1. NORTH AMERICA RESEARCH-GRADE PROTEINS MARKET,
7.3.2. U.S.
7.3.2.1. KEY COUNTRY DYNAMICS
7.3.2.2. COMPETITIVE SCENARIO
7.3.2.3. U.S. RESEARCH-GRADE PROTEINS MARKET,
7.3.3. CANADA
7.3.3.1. KEY COUNTRY DYNAMICS
7.3.3.2. COMPETITIVE SCENARIO
7.3.3.3. CANADA RESEARCH-GRADE PROTEINS MARKET,
7.4. EUROPE
7.4.1. EUROPE RESEARCH-GRADE PROTEINS MARKET,
7.4.2. UK
7.4.2.1. KEY COUNTRY DYNAMICS
7.4.2.2. COMPETITIVE SCENARIO
7.4.2.3. UK RESEARCH-GRADE PROTEINS MARKET,
7.4.3. GERMANY
7.4.3.1. KEY COUNTRY DYNAMICS
7.4.3.2. COMPETITIVE SCENARIO
7.4.3.3. GERMANY RESEARCH-GRADE PROTEINS MARKET,
7.4.4. SPAIN
7.4.4.1. KEY COUNTRY DYNAMICS
7.4.4.2. COMPETITIVE SCENARIO
7.4.4.3. SPAIN RESEARCH-GRADE PROTEINS MARKET,
7.4.5. FRANCE
7.4.5.1. KEY COUNTRY DYNAMICS
7.4.5.2. COMPETITIVE SCENARIO
7.4.5.3. FRANCE RESEARCH-GRADE PROTEINS MARKET,
7.4.6. ITALY
7.4.6.1. KEY COUNTRY DYNAMICS
7.4.6.2. COMPETITIVE SCENARIO
7.4.6.3. ITALY RESEARCH-GRADE PROTEINS MARKET,
7.4.7. DENMARK
7.4.7.1. KEY COUNTRY DYNAMICS
7.4.7.2. COMPETITIVE SCENARIO
7.4.7.3. DENMARK RESEARCH-GRADE PROTEINS MARKET,
7.4.8. SWEDEN
7.4.8.1. KEY COUNTRY DYNAMICS
7.4.8.2. COMPETITIVE SCENARIO
7.4.8.3. SWEDEN RESEARCH-GRADE PROTEINS MARKET,
7.4.9. NORWAY
7.4.9.1. KEY COUNTRY DYNAMICS
7.4.9.2. COMPETITIVE SCENARIO
7.4.9.3. NORWAY RESEARCH-GRADE PROTEINS MARKET,
7.5. ASIA PACIFIC
7.5.1. ASIA-PACIFIC RESEARCH-GRADE PROTEINS MARKET,
7.5.2. JAPAN
7.5.2.1. KEY COUNTRY DYNAMICS
7.5.2.2. COMPETITIVE SCENARIO
7.5.2.3. JAPAN RESEARCH-GRADE PROTEINS MARKET,
7.5.3. CHINA
7.5.3.1. KEY COUNTRY DYNAMICS
7.5.3.2. COMPETITIVE SCENARIO
7.5.3.3. CHINA RESEARCH-GRADE PROTEINS MARKET,
7.5.4. INDIA
7.5.4.1. KEY COUNTRY DYNAMICS
7.5.4.2. COMPETITIVE SCENARIO
7.5.4.3. INDIA RESEARCH-GRADE PROTEINS MARKET,
7.5.5. SOUTH KOREA
7.5.5.1. KEY COUNTRY DYNAMICS
7.5.5.2. COMPETITIVE SCENARIO
7.5.5.3. SOUTH KOREA RESEARCH-GRADE PROTEINS MARKET,
7.5.6. THAILAND
7.5.6.1. KEY COUNTRY DYNAMICS
7.5.6.2. COMPETITIVE SCENARIO
7.5.6.3. THAILAND RESEARCH-GRADE PROTEINS MARKET,
7.5.7. AUSTRALIA
7.5.7.1. KEY COUNTRY DYNAMICS
7.5.7.2. COMPETITIVE SCENARIO
7.5.7.3. AUSTRALIA RESEARCH-GRADE PROTEINS MARKET,
7.6. LATIN AMERICA
7.6.1. LATIN AMERICA RESEARCH-GRADE PROTEINS MARKET,
7.6.2. BRAZIL
7.6.2.1. KEY COUNTRY DYNAMICS
7.6.2.2. COMPETITIVE SCENARIO
7.6.2.3. BRAZIL RESEARCH-GRADE PROTEINS MARKET,
7.6.3. ARGENTINA
7.6.3.1. KEY COUNTRY DYNAMICS
7.6.3.2. COMPETITIVE SCENARIO
7.6.3.3. ARGENTINA RESEARCH-GRADE PROTEINS MARKET,
7.7. MEA
7.7.1. MEA RESEARCH-GRADE PROTEINS MARKET,
7.7.2. SOUTH AFRICA
7.7.2.1. KEY COUNTRY DYNAMICS
7.7.2.2. COMPETITIVE SCENARIO
7.7.2.3. SOUTH AFRICA RESEARCH-GRADE PROTEINS MARKET,
7.7.3. SAUDI ARABIA
7.7.3.1. KEY COUNTRY DYNAMICS
7.7.3.2. COMPETITIVE SCENARIO
7.7.3.3. SAUDI ARABIA RESEARCH-GRADE PROTEINS MARKET,
7.7.4. UAE
7.7.4.1. KEY COUNTRY DYNAMICS
7.7.4.2. COMPETITIVE SCENARIO
7.7.4.3. UAE RESEARCH-GRADE PROTEINS MARKET,
7.7.5. KUWAIT
7.7.5.1. KEY COUNTRY DYNAMICS
7.7.5.2. COMPETITIVE SCENARIO
7.7.5.3. KUWAIT RESEARCH-GRADE PROTEINS MARKET,
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. COMPANY CATEGORIZATION
8.2. STRATEGY MAPPING
8.3. COMPANY POSITION ANALYSIS, 2024
8.4. COMPANY PROFILES/LISTING
8.4.1. THERMO FISHER SCIENTIFIC, INC.
8.4.1.1. COMPANY OVERVIEW
8.4.1.2. FINANCIAL PERFORMANCE
8.4.1.3. PRODUCT BENCHMARKING
8.4.1.4. STRATEGIC INITIATIVES
8.4.2. ABCAM PLC
8.4.2.1. COMPANY OVERVIEW
8.4.2.2. FINANCIAL PERFORMANCE
8.4.2.3. PRODUCT BENCHMARKING
8.4.2.4. STRATEGIC INITIATIVES
8.4.3. MILTENYI BIOTEC
8.4.3.1. COMPANY OVERVIEW
8.4.3.2. PRODUCT BENCHMARKING
8.4.3.3. STRATEGIC INITIATIVES
8.4.4. GENSCRIPT
8.4.4.1. COMPANY OVERVIEW
8.4.4.2. FINANCIAL PERFORMANCE
8.4.4.3. PRODUCT BENCHMARKING
8.4.4.4. STRATEGIC INITIATIVES
8.4.5. BIO-TECHNE
8.4.5.1. COMPANY OVERVIEW
8.4.5.2. FINANCIAL PERFORMANCE
8.4.5.3. PRODUCT BENCHMARKING
8.4.5.4. STRATEGIC INITIATIVES
8.4.6. PROTEINTECH GROUP, INC.
8.4.6.1. COMPANY OVERVIEW
8.4.6.2. PRODUCT BENCHMARKING
8.4.6.3. STRATEGIC INITIATIVES
8.4.7. ACROBIOSYSTEMS
8.4.7.1. COMPANY OVERVIEW
8.4.7.2. PRODUCT BENCHMARKING
8.4.7.3. STRATEGIC INITIATIVES
8.4.8. SINO BIOLOGICAL, INC.
8.4.8.1. COMPANY OVERVIEW
8.4.8.2. PRODUCT BENCHMARKING
8.4.8.3. STRATEGIC INITIATIVES
8.4.9. PROSPEC-TANY TECHNOGENE LTD.
8.4.9.1. COMPANY OVERVIEW
8.4.9.2. PRODUCT BENCHMARKING
8.4.9.3. STRATEGIC INITIATIVES
8.4.10. NEW ENGLAND BIOLABS
8.4.10.1. COMPANY OVERVIEW
8.4.10.2. PRODUCT BENCHMARKING
8.4.10.3. STRATEGIC INITIATIVES
著作権 ©2022 無断複写・転載を禁じます
